Cargando…
Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework
OBJECTIVES: To explore reasons for the lack of uptake of ‘Better Care Better Value (BCBV)’ prescribing indicators for renin–angiotensin–aldosterone system (RAAS) inhibitors and identify learning lessons to inform the implementation of future prescribing policies. DESIGN: In-depth, semistructured int...
Autores principales: | Kurdi, Amanj, Elliott, Rachel Ann, Chen, Li-Chia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312337/ https://www.ncbi.nlm.nih.gov/pubmed/32580986 http://dx.doi.org/10.1136/bmjopen-2019-035910 |
Ejemplares similares
-
The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design
por: Baker, Amanj, et al.
Publicado: (2015) -
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
por: Kurdi, Amanj, et al.
Publicado: (2022) -
A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
por: Kurdi, Amanj, et al.
Publicado: (2020) -
General practitioners’ views of clinically led commissioning: cross-sectional survey in England
por: Moran, Valerie, et al.
Publicado: (2017) -
What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences
por: Chapman, Stephen R, et al.
Publicado: (2017)